{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T08:40:59Z","timestamp":1791362459439,"version":"4.3.1"},"publisher-location":"Cham","reference-count":182,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783030105600","type":"print"},{"value":"9783030105617","type":"electronic"}],"license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018]]},"DOI":"10.1007\/164_2018_160","type":"book-chapter","created":{"date-parts":[[2018,9,7]],"date-time":"2018-09-07T12:12:01Z","timestamp":1536322321000},"page":"3-49","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Responding to New Psychoactive Substances in the European Union: Early Warning, Risk Assessment, and Control Measures"],"prefix":"10.1007","author":[{"given":"Michael","family":"Evans-Brown","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roumen","family":"Sedefov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,9,8]]},"reference":[{"key":"160_CR1","unstructured":"96\/750\/JHA (1996) Joint Action of 17 December 1996 adopted by the Council on the basis of Article K.3 of the Treaty on European Union concerning the approximation of the laws and practices of the Member States of the European Union to combat drug addiction and to prevent and combat illegal drug trafficking. Off J Eur Union L342:6\u20138. https:\/\/eur-lex.europa.eu\/legal-content\/EN\/ALL\/?uri=CELEX:31996F0750"},{"key":"160_CR2","unstructured":"97\/396\/JHA (1997) Joint Action of 16 June 1997 adopted by the Council on the basis of Article K.3 of the Treaty on European Union, concerning the information exchange, risk assessment and the control of new synthetic drugs. Off J Eur Union L167:1\u20133. https:\/\/eur-lex.europa.eu\/legal-content\/en\/TXT\/?uri=CELEX:31997F0396"},{"key":"160_CR3","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1002\/dta.1728","volume":"7","author":"V Abbate","year":"2015","unstructured":"Abbate V, Kicman AT, Evans-Brown M, McVeigh J, Cowan DA, Wilson C, Coles SJ, Walker CJ (2015) Anabolic steroids detected in bodybuilding dietary supplements \u2013 a significant risk to public health. Drug Test Anal 7:609\u2013618. https:\/\/doi.org\/10.1002\/dta.1728","journal-title":"Drug Test Anal"},{"key":"160_CR4","doi-asserted-by":"publisher","first-page":"e5","DOI":"10.1016\/j.forsciint.2016.02.024","volume":"261","author":"P Adamowicz","year":"2016","unstructured":"Adamowicz P (2016) Fatal intoxication with synthetic cannabinoid MDMB-CHMICA. Forensic Sci Int 261:e5\u2013e10. https:\/\/doi.org\/10.1016\/j.forsciint.2016.02.024","journal-title":"Forensic Sci Int"},{"key":"160_CR5","first-page":"36","volume":"4","author":"Anonymous","year":"1953","unstructured":"Anonymous (1953) Esters of morphine. Bull Narc 4:36\u201338 https:\/\/www.unodc.org\/unodc\/en\/data-and-analysis\/bulletin\/bulletin_1953-01-01_2_page009.html","journal-title":"Bull Narc"},{"key":"160_CR6","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1002\/jms.1558","volume":"44","author":"V Auw\u00e4rter","year":"2009","unstructured":"Auw\u00e4rter V, Dresen S, Weinmann W, Muller M, Putz M, Ferreiros N (2009) \u2018Spice\u2019 and other herbal blends: harmless incense or cannabinoid designer drugs? J Mass Spectrom 44:832\u2013837. https:\/\/doi.org\/10.1002\/jms.1558","journal-title":"J Mass Spectrom"},{"key":"160_CR7","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1159\/000355268","volume":"20","author":"CR Baird","year":"2014","unstructured":"Baird CR, Fox P, Colvin LA (2014) Gabapentinoid abuse in order to potentiate the effect of methadone: a survey among substance misusers. Eur Addict Res 20:115\u2013118. https:\/\/doi.org\/10.1159\/000355268","journal-title":"Eur Addict Res"},{"issue":"7","key":"160_CR8","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1093\/jat\/bky023","volume":"42","author":"Erica L Bakota","year":"2018","unstructured":"Bakota EL, Samms WC, Gray TR, Oleske DA, Hines MO (2018) Case reports of fatalities involving tianeptine in the United States. J Anal Toxicol. https:\/\/doi.org\/10.1093\/jat\/bky023","journal-title":"Journal of Analytical Toxicology"},{"key":"160_CR9","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1021\/acschemneuro.6b00137","volume":"7","author":"SD Banister","year":"2016","unstructured":"Banister SD, Longworth M, Kevin R, Sachdev S, Santiago M, Stuart J, Mack JB, Glass M, McGregor IS, Connor M, Kassiou M (2016) Pharmacology of valinate and tert-leucinate synthetic cannabinoids 5F-AMBICA, 5F-AMB, 5F-ADB, AMB-FUBINACA, MDMB-FUBINACA, MDMB-CHMICA, and their analogues. ACS Chem Neurosci 7:1241\u20131254. https:\/\/doi.org\/10.1021\/acschemneuro.6b00137","journal-title":"ACS Chem Neurosci"},{"key":"160_CR10","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1021\/cen-v063n036.p007","volume":"63","author":"RM Baum","year":"1985","unstructured":"Baum RM (1985) New variety of street drugs poses growing problem. Chem Eng News 63:7\u201316","journal-title":"Chem Eng News"},{"key":"160_CR11","volume-title":"Pursuit of ecstasy: the MDMA experience","author":"J Beck","year":"1994","unstructured":"Beck J, Rosenbaum M (1994) Pursuit of ecstasy: the MDMA experience. State University of New York Press, Albany"},{"key":"160_CR12","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1016\/S0140-6736(96)90981-2","volume":"347","author":"AI Berens","year":"1996","unstructured":"Berens AI, Voets AJ, Demedts P (1996) Illicit fentanyl in Europe. Lancet 347:1334\u20131335. https:\/\/doi.org\/10.1016\/S0140-6736(96)90981-2","journal-title":"Lancet"},{"key":"160_CR13","volume-title":"Demons: our changing attitudes to alcohol, tobacco, and drugs","author":"V Berridge","year":"2013","unstructured":"Berridge V (2013) Demons: our changing attitudes to alcohol, tobacco, and drugs. Oxford University Press, Oxford"},{"key":"160_CR14","volume-title":"Opium and the people: opiate use in nineteenth-century England","author":"V Berridge","year":"1981","unstructured":"Berridge V, Edwards G (1981) Opium and the people: opiate use in nineteenth-century England. Allen Lane, Penguin Books Ltd., London"},{"key":"160_CR15","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.drugpo.2016.10.015","volume":"40","author":"S Blackman","year":"2017","unstructured":"Blackman S, Bradley R (2017) From niche to stigma-Headshops to prison: exploring the rise and fall of synthetic cannabinoid use among young adults. Int J Drug Policy 40:70\u201377. https:\/\/doi.org\/10.1016\/j.drugpo.2016.10.015","journal-title":"Int J Drug Policy"},{"key":"160_CR16","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1002\/dta.1686","volume":"6","author":"S Brandt","year":"2014","unstructured":"Brandt S, King L, Evans-Brown M (2014) The new drug phenomenon. Drug Test Anal 6:587\u2013597. https:\/\/doi.org\/10.1002\/dta.1686","journal-title":"Drug Test Anal"},{"key":"160_CR17","volume-title":"Gentleman\u2019s Club: international control of drugs and alcohol","author":"K Brunn","year":"1975","unstructured":"Brunn K (1975) Gentleman\u2019s Club: international control of drugs and alcohol. University of Chicago Press, Chicago"},{"issue":"3\u20134","key":"160_CR18","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1002\/dta.1953","volume":"8","author":"PA Cohen","year":"2016","unstructured":"Cohen PA, Venhuis BJ, Brandt SD (2016) Advancing supplement science: challenges and solutions. Drug Test Anal 8(3\u20134):e1\u2013e3. https:\/\/doi.org\/10.1002\/dta.1953","journal-title":"Drug Test Anal"},{"key":"160_CR19","volume-title":"The story of ecstasy culture and acid house","author":"M Collin","year":"1997","unstructured":"Collin M (1997) The story of ecstasy culture and acid house. Serpent\u2019s Tail, London"},{"key":"160_CR20","unstructured":"Convention on Psychotropic Substances (1971) http:\/\/www.unodc.org\/unodc\/en\/treaties\/psychotropics.html . Accessed 11 Jun 2018"},{"key":"160_CR21","unstructured":"Cooper DA (1988) Future synthetic drugs of abuse. In: Castonguay RT (ed) In: Proceedings of the international symposium on the forensic aspects of controlled substances: March 28\u2013April 1. Laboratory Division, Federal Bureau of Investigation, US Dept. of Justice, Washington, DC, pp 79\u2013103"},{"key":"160_CR22","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1007\/s11920-11016-10694-11921","volume":"18","author":"ZD Cooper","year":"2016","unstructured":"Cooper ZD (2016) Adverse effects of synthetic cannabinoids: management of acute toxicity and withdrawal. Curr Psychiatry Rep 18:52. https:\/\/doi.org\/10.1007\/s11920-11016-10694-11921","journal-title":"Curr Psychiatry Rep"},{"key":"160_CR23","unstructured":"Council Decision 2005\/387\/JHA of 10 May 2005 on the information exchange, risk-assessment and control of new psychoactive substances (2005) Off J Eur Union L127:32\u201337. https:\/\/eur-lex.europa.eu\/legal-content\/en\/ALL\/?uri=CELEX%3A32005D0387"},{"key":"160_CR24","volume-title":"Forces of habit drugs and the making of the modern world","author":"DT Courtwright","year":"2002","unstructured":"Courtwright DT (2002) Forces of habit drugs and the making of the modern world. Harvard University Press, Cambridge"},{"key":"160_CR25","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/978-1-60761-993-2_3","volume-title":"The opiate receptors","author":"BM Cox","year":"2011","unstructured":"Cox BM (2011) Pharmacology of opioid drugs. In: Pasternak G (ed) The opiate receptors. Springer, New York, pp 23\u201358"},{"key":"160_CR26","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1097\/00000542-200105000-00021","volume":"94","author":"A Dahan","year":"2001","unstructured":"Dahan A, Sarton E, Teppema L, Olievier C, Nieuwenhuijs D, Matthes HW, Kieffer BL (2001) Anesthetic potency and influence of morphine and sevoflurane on respiration in mu-opioid receptor knockout mice. Anesthesiology 94:824\u2013832 http:\/\/anesthesiology.pubs.asahq.org\/article.aspx?articleid=1944782","journal-title":"Anesthesiology"},{"key":"160_CR27","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1097\/ALN.0b013e3181c38c25","volume":"112","author":"A Dahan","year":"2010","unstructured":"Dahan A, Aarts L, Smith TW (2010) Incidence, reversal, and prevention of opioid-induced respiratory depression. Anesthesiology 112:226\u2013238. https:\/\/doi.org\/10.1097\/ALN.0b013e3181c38c25","journal-title":"Anesthesiology"},{"key":"160_CR28","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/S0731-7085(02)00684-2","volume":"31","author":"D Boer de","year":"2003","unstructured":"de Boer D, Goemans WP, Ghezavat VR, van Ooijen RD, Maes RA (2003) Seizure of illicitly produced Para-fluorofentanyl: quantitative analysis of the content of capsules and tablets. J Pharm Biomed Anal 31:557\u2013562. https:\/\/doi.org\/10.1016\/S0731-7085(02)00684-2","journal-title":"J Pharm Biomed Anal"},{"key":"160_CR29","unstructured":"Decision No 1082\/2013\/EU of the European Parliament and of the Council of 22 October 2013 on serious cross-border threats to health and repealing Decision No 2119\/98\/EC (2013) Off J Eur Union L293:1\u201315. https:\/\/eur-lex.europa.eu\/legal-content\/GA\/ALL\/?uri=celex:32013D1082"},{"key":"160_CR30","doi-asserted-by":"publisher","DOI":"10.1201\/b17126","volume-title":"Safety differently: human factors for a new era","author":"S Dekker","year":"2014","unstructured":"Dekker S (2014) Safety differently: human factors for a new era, 2nd edn. CRC Press, Boca Raton","edition":"2"},{"key":"160_CR31","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1093\/jat\/bkx034","volume":"41","author":"SK Dempsey","year":"2017","unstructured":"Dempsey SK, Poklis JL, Sweat K, Cumpston K, Wolf CE (2017) Acute toxicity from intravenous use of the tricyclic antidepressant tianeptine. J Anal Toxicol 41:547\u2013550. https:\/\/doi.org\/10.1093\/jat\/bkx034","journal-title":"J Anal Toxicol"},{"key":"160_CR32","unstructured":"Deprez EE, Hui L, Wills K (2018) Deadly Chinese fentanyl is creating a new era of drug kingpins. Bloomberg. https:\/\/www.bloomberg.com\/news\/features\/2018-05-22\/deadly-chinese-fentanyl-is-creating-a-new-era-of-drug-kingpins . Accessed 11 June 2018"},{"key":"160_CR33","doi-asserted-by":"publisher","first-page":"209","DOI":"10.14745\/ccdr.v41i09a02","volume":"41","author":"M Dion","year":"2015","unstructured":"Dion M, AbdelMalik P, Mawudeku A (2015) Big data and the global public health intelligence network (GPHIN). Can Commun Dis Rep 41:209\u2013214","journal-title":"Can Commun Dis Rep"},{"key":"160_CR34","unstructured":"Directive (EU) 2017\/2103 of the European Parliament and of the Council of 15 November 2017 amending Council Framework Decision 2004\/757\/JHA in order to include new psychoactive substances in the definition of \u2018drug\u2019 and repealing Council Decision 2005\/387\/JHA (2017) Off J Eur Union L305:12\u201318. https:\/\/eur-lex.europa.eu\/legal-content\/en\/TXT\/?uri=CELEX:32017L2103"},{"key":"160_CR35","unstructured":"Directive 2011\/62\/EU of the European Parliament and of the Council of 8 June 2011 amending Directive 2001\/83\/EC on the Community code relating to medicinal products for human use, as regards the prevention of the entry into the legal supply chain of falsified medicinal products (2011) Off J Eur Union L174:74\u201387. https:\/\/eur-lex.europa.eu\/legal-content\/EN\/TXT\/?uri=celex:32011L0062"},{"key":"160_CR36","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1080\/15563650.2016.1278224","volume":"55","author":"M Dobaja","year":"2017","unstructured":"Dobaja M, Grenc D, Kozelj G, Brvar M (2017) Occupational transdermal poisoning with synthetic cannabinoid cumyl-PINACA. Clin Toxicol (Phila) 55:193\u2013195. https:\/\/doi.org\/10.1080\/15563650.2016.1278224","journal-title":"Clin Toxicol (Phila)"},{"key":"160_CR37","doi-asserted-by":"crossref","DOI":"10.1353\/book.3470","volume-title":"Psychedelic psychiatry. LSD from clinic to campus","author":"L Dyck","year":"2008","unstructured":"Dyck L (2008) Psychedelic psychiatry. LSD from clinic to campus. John Hopkins University Press, Baltimore"},{"issue":"4","key":"160_CR38","doi-asserted-by":"publisher","first-page":"e41","DOI":"10.1093\/jat\/bkx109","volume":"42","author":"Simon P Elliott","year":"2018","unstructured":"Elliott SP, Hernandez Lopez E (2018) A series of deaths involving carfentanil in the UK and associated post-mortem blood concentrations. J Anal Toxicol. https:\/\/doi.org\/10.1093\/jat\/bkx109","journal-title":"Journal of Analytical Toxicology"},{"key":"160_CR39","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.forsciint.2017.05.019","volume":"277","author":"L Ernst","year":"2017","unstructured":"Ernst L, Brandhorst K, Papke U, Altrogge A, Zodel S, Langer N, Beuerle T (2017) Identification and quantification of synthetic cannabinoids in \u2018spice-like\u2019 herbal mixtures: update of the German situation in early 2017. Forensic Sci Int 277:51\u201358. https:\/\/doi.org\/10.1016\/j.forsciint.2017.05.019","journal-title":"Forensic Sci Int"},{"key":"160_CR40","doi-asserted-by":"crossref","DOI":"10.1163\/9789004642669","volume-title":"Policies and strategies to combat drugs in Europe. The treaty on European Union: framework for a new European strategy to combat drugs?","author":"G Estievenart","year":"1995","unstructured":"Estievenart G (1995) Policies and strategies to combat drugs in Europe. The treaty on European Union: framework for a new European strategy to combat drugs? Martinus Nijhoff, Dordrecht"},{"key":"160_CR41","unstructured":"European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) (2007) Early-warning system on new psychoactive substances. Operating guidelines. Publications Office of the European Union, Luxembourg. https:\/\/publications.europa.eu\/en\/publication-detail\/-\/publication\/08497900-eaab-45fb-b918-b1697f90e8b8\/language-en . Accessed 11 June 2018"},{"key":"160_CR42","doi-asserted-by":"publisher","unstructured":"European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) (2009) Understanding the \u2018Spice\u2019 phenomenon. Office for Official Publications of the European Communities, Luxembourg. doi: https:\/\/doi.org\/10.2810\/27063 . Accessed 11 Jun 2018","DOI":"10.2810\/27063"},{"key":"160_CR43","doi-asserted-by":"publisher","unstructured":"European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) (2010) Risk assessment of new psychoactive substances. Operating guidelines. Publications Office of the European Union, Luxembourg. doi: https:\/\/doi.org\/10.2810\/2428 . Accessed 11 Jun 2018","DOI":"10.2810\/2428"},{"key":"160_CR44","doi-asserted-by":"publisher","unstructured":"European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) (2014a) Report on the risk assessment of 4-methylamphetamine in the framework of the council decision on new psychoactive substances, Publications Office of the European Union, Luxembourg. doi: https:\/\/doi.org\/10.2810\/86512 . Accessed 11 Jun 2018","DOI":"10.2810\/86512"},{"key":"160_CR45","doi-asserted-by":"publisher","unstructured":"European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) (2014b) Report on the risk assessment of 3,4-dichloro-N-{[1-(dimethylamino)cyclohexyl]methyl}benzamide (AH-7921) in the framework of the council decision on new psychoactive substances. Publications Office of the European Union, Luxembourg. doi: https:\/\/doi.org\/10.2810\/5691 . Accessed 11 Jun 2018","DOI":"10.2810\/5691"},{"key":"160_CR46","doi-asserted-by":"publisher","unstructured":"European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) (2016a) EU drug markets report. In: Depth analysis. Luxembourg, Publications Office of the European Union. doi: https:\/\/doi.org\/10.2810\/219411 . Accessed 11 Jun 2018","DOI":"10.2810\/219411"},{"key":"160_CR47","doi-asserted-by":"publisher","unstructured":"European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) (2016b) EMCDDA\u2013Europol joint report on a new psychoactive substance: N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl] acetamide (acetylfentanyl). Luxembourg, Publications Office of the European Union. doi: https:\/\/doi.org\/10.2810\/890694 . Accessed 11 Jun 2018","DOI":"10.2810\/890694"},{"key":"160_CR48","doi-asserted-by":"publisher","unstructured":"European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) (2016c) Preventing opioid overdose deaths with take-home naloxone. Luxembourg, Publications Office of the European Union. doi: https:\/\/doi.org\/10.2810\/357062 . Accessed 11 Jun 2018","DOI":"10.2810\/357062"},{"key":"160_CR49","doi-asserted-by":"publisher","unstructured":"European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) (2017a) Report on the risk assessment of N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide (Acryloylfentanyl) in the framework of the council decision on new psychoactive substances. Publications Office of the European Union, Luxembourg. doi: https:\/\/doi.org\/10.2810\/16112 . Accessed 11 Jun 2018","DOI":"10.2810\/16112"},{"key":"160_CR50","unstructured":"European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) (2017b) Synthetic cannabinoids in Europe. http:\/\/www.emcdda.europa.eu\/topics\/pods\/synthetic-cannabinoids_en . Accessed 11 Jun 2018"},{"key":"160_CR51","doi-asserted-by":"publisher","unstructured":"European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) (2017c) Report on the risk assessment of methyl 2-[[1-(cyclohexylmethyl)-1H-indole-3- carbonyl]amino]-3,3-dimethylbutanoate (MDMB-CHMICA) in the framework of the council decision on new psychoactive substances. Publications Office of the European Union, Luxembourg. doi: https:\/\/doi.org\/10.2810\/08132 . Accessed 11 Jun 2018","DOI":"10.2810\/08132"},{"key":"160_CR52","doi-asserted-by":"publisher","unstructured":"European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) (2017d) EMCDDA\u2013Europol joint report on a new psychoactive substance: methyl 1-(2-phenylethyl)-4-phenyl(propanoyl)aminopiperidine-4-carboxylate (carfentanil): in accordance with article 5 of council decision 2005\/387\/JHA on the information exchange, risk assessment and control of new psychoactive substances. Publications Office of the European Union, Luxembourg. doi: https:\/\/doi.org\/10.2810\/282222 . Accessed 11 Jun 2018","DOI":"10.2810\/282222"},{"key":"160_CR53","doi-asserted-by":"publisher","unstructured":"European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) (2018a) European drug report: trends and developments. Publications Office of the European Union, Luxembourg. doi: https:\/\/doi.org\/10.2810\/800331 . Accessed 11 Jun 2018","DOI":"10.2810\/800331"},{"key":"160_CR54","doi-asserted-by":"publisher","unstructured":"European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) (2018b) Fentanils and synthetic cannabinoids: driving greater complexity into the drug situation. An update from the EU early warning system (June 2018). Publications Office of the European Union, Luxembourg. doi: https:\/\/doi.org\/10.2810\/603753 . Accessed 11 Jun 2018","DOI":"10.2810\/603753"},{"key":"160_CR55","unstructured":"European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) (2018c) Mission. http:\/\/www.emcdda.europa.eu\/about\/mission . Accessed 11 Jun 2018"},{"key":"160_CR56","unstructured":"European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) (2018d) Reitox network. http:\/\/www.emcdda.europa.eu\/about\/partners\/reitox-network . Accessed 11 Jun 2018"},{"key":"160_CR57","unstructured":"European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) (2018e) Action on new drugs. http:\/\/www.emcdda.europa.eu\/activities\/action-on-new-drugs . Accessed 11 Jun 2018"},{"key":"160_CR58","doi-asserted-by":"publisher","unstructured":"European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) and Eurojust (2016) New psychoactive substances in Europe: legislation and prosecution \u2013 current challenges and solutions. Publications Office of the European Union, Luxembourg. doi: https:\/\/doi.org\/10.2810\/777512 . Accessed 11 Jun 2018","DOI":"10.2810\/777512"},{"key":"160_CR59","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1111\/add.13528","volume":"112","author":"M Evans-Brown","year":"2017","unstructured":"Evans-Brown M, Sedefov R (2017) New psychoactive substances: driving greater complexity into the drug problem. Addiction 112:36\u201338. https:\/\/doi.org\/10.1111\/add.13528","journal-title":"Addiction"},{"key":"160_CR60","doi-asserted-by":"publisher","first-page":"b566","DOI":"10.1136\/bmj.b566","volume":"338","author":"M Evans-Brown","year":"2009","unstructured":"Evans-Brown M, Dawson RT, Chandler M, McVeigh J (2009) Use of melanotan I and II in the general population. BMJ 338:b566. https:\/\/doi.org\/10.1136\/bmj.b566","journal-title":"BMJ"},{"key":"160_CR61","doi-asserted-by":"publisher","first-page":"g1476","DOI":"10.1136\/bmj.g1476","volume":"348","author":"M Evans-Brown","year":"2014","unstructured":"Evans-Brown M, Kimerg\u00e5rd A, McVeigh J, Chandler M, Brandt SD (2014) Is the breast cancer drug tamoxifen being sold as a bodybuilding dietary supplement? Br Med J 348:g1476. https:\/\/doi.org\/10.1136\/bmj.g1476","journal-title":"Br Med J"},{"key":"160_CR62","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1080\/10903127.2017.1315203","volume":"21","author":"M Faul","year":"2017","unstructured":"Faul M, Lurie P, Kinsman JM, Dailey MW, Crabaugh C, Sasser SM (2017) Multiple naloxone administrations among emergency medical service providers is increasing. Prehosp Emerg Care 21:411\u2013419. https:\/\/doi.org\/10.1080\/10903127.2017.1315203","journal-title":"Prehosp Emerg Care"},{"issue":"6","key":"160_CR63","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1177\/0004563218767462","volume":"55","author":"Loretta T Ford","year":"2018","unstructured":"Ford LT, Berg JD (2018) Analytical evidence to show letters impregnated with novel psychoactive substances are a means of getting drugs to inmates within the UK prison service. Ann Clin Biochem. https:\/\/doi.org\/10.1177\/0004563218767462","journal-title":"Annals of Clinical Biochemistry: International Journal of Laboratory Medicine"},{"key":"160_CR64","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.tips.2016.12.003","volume":"38","author":"BM Ford","year":"2017","unstructured":"Ford BM, Tai S, Fantegrossi WE, Prather PL (2017) Synthetic pot: not your grandfather\u2019s marijuana. Trends Pharmacol Sci 38:257\u2013276. https:\/\/doi.org\/10.1016\/j.tips.2016.12.003","journal-title":"Trends Pharmacol Sci"},{"key":"160_CR65","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1002\/dta.1975","volume":"9","author":"A Frinculescu","year":"2017","unstructured":"Frinculescu A, Lyall CL, Ramsey J, Miserez B (2017) Variation in commercial smoking mixtures containing third-generation synthetic cannabinoids. Drug Test Anal 9:327\u2013333. https:\/\/doi.org\/10.1002\/dta.1975","journal-title":"Drug Test Anal"},{"key":"160_CR66","first-page":"149","volume":"196","author":"G Fritschi","year":"1995","unstructured":"Fritschi G, Klein B (1995) Zwischen- und nebenproduckte bei der illegalen herstellung von fentanyl und fluorofentanylen und die synthese hirer acetylhomologen. Arch Kriminol 196:149\u2013155","journal-title":"Arch Kriminol"},{"key":"160_CR67","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1021\/ja01062a046","volume":"86","author":"Y Gaoni","year":"1964","unstructured":"Gaoni Y, Mechoulam R (1964) Isolation, structure, and partial synthesis of an active constituent of hashish. J Am Chem Soc 86:1646\u20131647. https:\/\/doi.org\/10.1021\/ja01062a046","journal-title":"J Am Chem Soc"},{"key":"160_CR68","doi-asserted-by":"publisher","first-page":"837","DOI":"10.15585\/mmwr.mm6533a2","volume":"65","author":"RM Gladden","year":"2016","unstructured":"Gladden RM, Martinez P, Seth P (2016) Fentanyl law enforcement submissions and increases in synthetic opioid-involved overdose deaths \u2013 27 states, 2013\u20132014. MMWR Morb Mortal Wkly Rep 65:837\u2013843. https:\/\/doi.org\/10.15585\/mmwr.mm6533a2","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"160_CR69","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1111\/add.12287","volume":"108","author":"P Griffiths","year":"2013","unstructured":"Griffiths P, Evans-Brown M, Sedefov R (2013) Getting up to speed with the public health and regulatory challenges posed by new psychoactive substances in the information age. Addiction 108:1700\u20131703. https:\/\/doi.org\/10.1111\/add.12287","journal-title":"Addiction"},{"key":"160_CR70","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1093\/jat\/bkw129","volume":"41","author":"D Guerrieri","year":"2017","unstructured":"Guerrieri D, Rapp E, Roman M, Druid H, Kronstrand R (2017a) Postmortem and toxicological findings in a series of furanylfentanyl-related deaths. J Anal Toxicol 41:242\u2013249. https:\/\/doi.org\/10.1093\/jat\/bkw129","journal-title":"J Anal Toxicol"},{"key":"160_CR71","doi-asserted-by":"publisher","first-page":"e21","DOI":"10.1016\/j.forsciint.2017.05.010","volume":"277","author":"D Guerrieri","year":"2017","unstructured":"Guerrieri D, Rapp E, Roman M, Thelander G, Kronstrand R (2017b) Acrylfentanyl: another new psychoactive drug with fatal consequences. Forensic Sci Int 277:e21\u2013e29. https:\/\/doi.org\/10.1016\/j.forsciint.2017.05.010","journal-title":"Forensic Sci Int"},{"key":"160_CR72","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.forsciint.2014.04.028","volume":"241","author":"M H\u00e4kkinen","year":"2014","unstructured":"H\u00e4kkinen M, Vuori E, Kalso E, Gergov M, Ojanpera I (2014) Profiles of pregabalin and gabapentin abuse by postmortem toxicology. Forensic Sci Int 241:1\u20136. https:\/\/doi.org\/10.1016\/j.forsciint.2014.04.028","journal-title":"Forensic Sci Int"},{"key":"160_CR73","unstructured":"Halford B (2015) A glimpse inside the sophisticated world of synthetic cannabinoids. Chem Eng News. http:\/\/cen.acs.org\/articles\/93\/web\/2015\/04\/Glimpse-Inside-Sophisticated-World-Synthetic.html . Accessed 11 June 2018"},{"key":"160_CR74","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1111\/1469-0691.12273","volume":"19","author":"DM Hartley","year":"2013","unstructured":"Hartley DM, Nelson NP, Arthur RR, Barboza P, Collier N, Lightfoot N, Linge JP, van der Goot E, Mawudeku A, Madoff LC, Vaillant L, Walters R, Yangarber R, Mantero J, Corley CD, Brownstein JS (2013) An overview of internet biosurveillance. Clin Microbiol Infect 19:1006\u20131013. https:\/\/doi.org\/10.1111\/1469-0691.12273","journal-title":"Clin Microbiol Infect"},{"key":"160_CR75","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1080\/15563650.2017.1303141","volume":"55","author":"A Helander","year":"2017","unstructured":"Helander A, Backberg M, Signell P, Beck O (2017) Intoxications involving acrylfentanyl and other novel designer fentanyls \u2013 results from the Swedish STRIDA project. Clin Toxicol (Phila) 55:589\u2013599. https:\/\/doi.org\/10.1080\/15563650.2017.1303141","journal-title":"Clin Toxicol (Phila)"},{"key":"160_CR76","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1520\/JFS11976J","volume":"33","author":"GL Henderson","year":"1988","unstructured":"Henderson GL (1988) Designer drugs: past history and future prospects. J Forensic Sci 33:569\u2013575","journal-title":"J Forensic Sci"},{"key":"160_CR77","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1520\/JFS13045J","volume":"36","author":"GL Henderson","year":"1991","unstructured":"Henderson GL (1991) Fentanyl-related deaths: demographics, circumstances, and toxicology of 112 cases. J Forensic Sci 36:422\u2013433","journal-title":"J Forensic Sci"},{"key":"160_CR78","unstructured":"Her Majesty\u2019s Inspectorate of Prisons (HMIP) (2015) Changing patterns of substance misuse in adult prisons and service responses. Her Majesty's Inspectorate of Prisons, London. https:\/\/www.justiceinspectorates.gov.uk\/hmiprisons\/wp-content\/uploads\/sites\/4\/2015\/12\/Substance-misuse-web-2015.pdf . Accessed 11 Jun 2018"},{"key":"160_CR79","doi-asserted-by":"crossref","DOI":"10.1353\/book.501","volume-title":"Happy pills in America: from Miltown to Prozac","author":"D Herzberg","year":"2010","unstructured":"Herzberg D (2010) Happy pills in America: from Miltown to Prozac. Johns Hopkins University Press, Baltimore"},{"key":"160_CR80","first-page":"207","volume-title":"Prescribed: writing, filling, using, and abusing the prescription in modern America","author":"D Herzberg","year":"2012","unstructured":"Herzberg D (2012) Busted for blockbusters: \u201cscrip mills\u201d, quaaludes, and prescribing power in the 1970s. In: Greene J, Watkins E (eds) Prescribed: writing, filling, using, and abusing the prescription in modern America. Johns Hopkins University Press, Baltimore, pp 207\u2013231"},{"key":"160_CR81","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.forsciint.2017.11.036","volume":"282","author":"L Hikin","year":"2018","unstructured":"Hikin L, Smith PR, Ringland E, Hudson S, Morley SR (2018) Multiple fatalities in the North of England associated with synthetic fentanyl analogue exposure: detection and quantitation a case series from early 2017. Forensic Sci Int 282:179\u2013183. https:\/\/doi.org\/10.1016\/j.forsciint.2017.11.036","journal-title":"Forensic Sci Int"},{"key":"160_CR82","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1080\/15563650.2016.1190980","volume":"54","author":"SL Hill","year":"2016","unstructured":"Hill SL, Najafi J, Dunn M, Acheampong P, Kamour A, Grundlingh J, Blain PG, Thomas SH (2016) Clinical toxicity following analytically confirmed use of the synthetic cannabinoid receptor agonist MDMB-CHMICA. A report from the identification of novel psychoActive substances (IONA) study. Clin Toxicol (Phila) 54:638\u2013643. https:\/\/doi.org\/10.1080\/15563650.2016.1190980","journal-title":"Clin Toxicol (Phila)"},{"key":"160_CR83","doi-asserted-by":"publisher","first-page":"587","DOI":"10.15585\/mmwr.mm6720a5","volume":"67","author":"RZ Horth","year":"2018","unstructured":"Horth RZ, Crouch B, Horowitz BZ, Prebish A, Slawson M, McNair J, Elsholz C, Gilley S, Robertson J, Risk I, Hill M, Fletcher L, Hou W, Peterson D, Adams K, Vitek D, Nakashima A, Dunn A (2018) Acute poisonings from a synthetic cannabinoid sold as cannabidiol \u2013 Utah, 2017\u20132018. MMWR Morb Mortal Wkly Rep 67:587\u2013588. https:\/\/doi.org\/10.15585\/mmwr.mm6720a5","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"160_CR84","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1001\/archpsyc.58.4.322","volume":"58","author":"MA Huestis","year":"2001","unstructured":"Huestis MA, Gorelick DA, Heishman SJ, Preston KL, Nelson RA, Moolchan ET, Frank RA (2001) Blockade of effects of smoked marijuana by the CB1-selective cannabinoid receptor antagonist SR141716. Arch Gen Psychiatry 58:322\u2013328. https:\/\/doi.org\/10.1001\/archpsyc.58.4.322","journal-title":"Arch Gen Psychiatry"},{"key":"160_CR85","unstructured":"Jack H (2009) The story of spice. Financial times. https:\/\/www.ft.com\/content\/1721e2da-f8a0-11dd-aae8-000077b07658 . Accessed 11 Jun 2018"},{"key":"160_CR86","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1111\/j.1399-6576.1982.tb01765.x","volume":"26","author":"PA Janssen","year":"1982","unstructured":"Janssen PA (1982) Potent, new analgesics, tailor-made for different purposes. Acta Anaesthesiol Scand 26:262\u2013268. https:\/\/doi.org\/10.1111\/j.1399-6576.1982.tb01765.x","journal-title":"Acta Anaesthesiol Scand"},{"key":"160_CR87","first-page":"25","volume-title":"Drugs affecting the central nervous system","author":"PAJ Janssen","year":"1968","unstructured":"Janssen PAJ, Van der Eycken CAM (1968) The chemical anatomy of potent morphine-like analgesics. In: Burger A (ed) Drugs affecting the central nervous system, vol 2. Marcel Dekker, New York, pp 25\u201360"},{"key":"160_CR88","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.15585\/mmwr.mm6439a7","volume":"64","author":"AM Kasper","year":"2015","unstructured":"Kasper AM, Ridpath AD, Arnold JK, Chatham-Stephens K, Morrison M, Olayinka O, Parker C, Galli R, Cox R, Preacely N, Anderson J, Kyle PB, Gerona R, Martin C, Schier J, Wolkin A, Dobbs T (2015) Severe illness associated with reported use of synthetic cannabinoids \u2013 Mississippi, April 2015. MMWR Morb Mortal Wkly Rep 64:1121\u20131122. https:\/\/doi.org\/10.15585\/mmwr.mm6439a7","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"160_CR89","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/S0165-6147(98)01279-6","volume":"20","author":"BL Kieffer","year":"1999","unstructured":"Kieffer BL (1999) Opioids: first lessons from knockout mice. Trends Pharmacol Sci 20:19\u201326. https:\/\/doi.org\/10.1016\/S0165-6147(98)01279-6","journal-title":"Trends Pharmacol Sci"},{"key":"160_CR90","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1517\/14740338.2015.1037274","volume":"14","author":"HK Kim","year":"2015","unstructured":"Kim HK, Nelson LS (2015) Reducing the harm of opioid overdose with the safe use of naloxone: a pharmacologic review. Expert Opin Drug Saf 14:1137\u20131146. https:\/\/doi.org\/10.1517\/14740338.2015.1037274","journal-title":"Expert Opin Drug Saf"},{"key":"160_CR91","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.15585\/mmwr.mm6537a6","volume":"65","author":"SA Klar","year":"2016","unstructured":"Klar SA, Brodkin E, Gibson E, Padhi S, Predy C, Green C, Lee V (2016) Furanyl-fentanyl overdose events caused by smoking contaminated crack cocaine \u2013 British Columbia, Canada, July 15\u201318, 2016. MMWR Morb Mortal Wkly Rep 65:1015\u20131016. https:\/\/doi.org\/10.15585\/mmwr.mm6537a6","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"160_CR92","doi-asserted-by":"publisher","first-page":"1379A","DOI":"10.1021\/ac00235a790","volume":"53","author":"TC Kram","year":"1981","unstructured":"Kram TC, Cooper DA, Allen AC (1981) Behind the identification of China white. Anal Chem 53:1379A\u20131386A","journal-title":"Anal Chem"},{"key":"160_CR93","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/S0379-0738(97)00068-6","volume":"88","author":"R Kronstrand","year":"1997","unstructured":"Kronstrand R, Druid H, Holmgren P, Rajs J (1997) A cluster of fentanyl-related deaths among drug addicts in Sweden. Forensic Sci Int 88:185\u2013195. https:\/\/doi.org\/10.1016\/S0379-0738(97)00068-6","journal-title":"Forensic Sci Int"},{"key":"160_CR94","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1002\/dta.1499","volume":"6","author":"N Langer","year":"2014","unstructured":"Langer N, Lindigkeit R, Schiebel HM, Ernst L, Beuerle T (2014) Identification and quantification of synthetic cannabinoids in \u2018spice-like\u2019 herbal mixtures: a snapshot of the German situation in the autumn of 2012. Drug Test Anal 6:59\u201371. https:\/\/doi.org\/10.1002\/dta.1499","journal-title":"Drug Test Anal"},{"key":"160_CR95","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.forsciint.2016.10.023","volume":"269","author":"N Langer","year":"2016","unstructured":"Langer N, Lindigkeit R, Schiebel HM, Papke U, Ernst L, Beuerle T (2016) Identification and quantification of synthetic cannabinoids in \"spice-like\" herbal mixtures: update of the German situation for the spring of 2016. Forensic Sci Int 269:31\u201341. https:\/\/doi.org\/10.1016\/j.forsciint.2016.10.023","journal-title":"Forensic Sci Int"},{"key":"160_CR96","doi-asserted-by":"crossref","unstructured":"Levinson M (2016) The box: how the shipping container made the world smaller and the world economy bigger. In: Princeton University Press, Princeton","DOI":"10.1515\/9781400880751"},{"key":"160_CR97","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1007\/978-3-642-29262-0_26","volume-title":"Electronic healthcare","author":"JP Linge","year":"2012","unstructured":"Linge JP, Mantero J, Fuart F, Belyaeva J, Atkinson M, van der Goot E (2012) Tracking media reports on the Shiga toxin-producing Escherichia coli O104: H4 outbreak in Germany. In: Kostkova P, Szomszor M, Fowler D (eds) Electronic healthcare. Springer, Berlin, pp 178\u2013185. https:\/\/doi.org\/10.1007\/978-3-642-29262-0_26"},{"key":"160_CR98","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1111\/dar.12225","volume":"34","author":"V Macfarlane","year":"2015","unstructured":"Macfarlane V, Christie G (2015) Synthetic cannabinoid withdrawal: a new demand on detoxification services. Drug Alcohol Rev 34:147\u2013153. https:\/\/doi.org\/10.1111\/dar.12225","journal-title":"Drug Alcohol Rev"},{"key":"160_CR99","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1213\/ANE.0b013e3182691898","volume":"115","author":"DB Macleod","year":"2012","unstructured":"Macleod DB, Habib AS, Ikeda K, Spyker DA, Cassella JV, Ho KY, Gan TJ (2012) Inhaled fentanyl aerosol in healthy volunteers: pharmacokinetics and pharmacodynamics. Anesth Analg 115:1071\u20131077. https:\/\/doi.org\/10.1213\/ANE.0b013e3182691898","journal-title":"Anesth Analg"},{"issue":"18","key":"160_CR100","doi-asserted-by":"publisher","first-page":"20796","DOI":"10.2807\/1560-7917.ES2014.19.18.20796","volume":"19","author":"J Mantero","year":"2014","unstructured":"Mantero J, Szegedi E, Payne Hallstrom L, Lenglet A, Depoortere E, Kaic B, Blumberg L, Linge JP, Coulombier D (2014) Enhanced epidemic intelligence using a web-based screening system during the 2010 FIFA World Cup in South Africa. Euro Surveill 19(18):20796 http:\/\/www.eurosurveillance.org\/ViewArticle.aspx?ArticleId=20796","journal-title":"Euro Surveill"},{"issue":"11","key":"160_CR101","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1080\/15563650.2018.1476694","volume":"56","author":"Jeanna M. Marraffa","year":"2018","unstructured":"Marraffa JM, Stork CM, Hoffman RS, Su MK (2018) Poison control center experience with tianeptine: an unregulated pharmaceutical product with potential for abuse. Clin Toxicol (Phila):1\u20134. https:\/\/doi.org\/10.1080\/15563650.2018.1476694","journal-title":"Clinical Toxicology"},{"key":"160_CR102","doi-asserted-by":"publisher","first-page":"k2270","DOI":"10.1136\/bmj.k2270","volume":"361","author":"J Martin","year":"2018","unstructured":"Martin J, Cunliffe J, D\u00e9cary-H\u00e9tu D, Aldridge J (2018) Effect of restricting the legal supply of prescription opioids on buying through online illicit marketplaces: interrupted time series analysis. BMJ 361:k2270. https:\/\/doi.org\/10.1136\/bmj.k2270","journal-title":"BMJ"},{"key":"160_CR103","volume-title":"Drug diplomacy in the twentieth century: an international history","author":"WB McAllister","year":"1999","unstructured":"McAllister WB (1999) Drug diplomacy in the twentieth century: an international history. Routledge, Abingdon"},{"key":"160_CR104","first-page":"309","volume":"108","author":"S McNamara","year":"2015","unstructured":"McNamara S, Stokes S, Kilduff R, Shine A (2015) Pregabalin abuse amongst opioid substitution treatment patients. Ir Med J 108:309\u2013310","journal-title":"Ir Med J"},{"key":"160_CR105","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1080\/02791072.1968.10524531","volume":"1","author":"FH Meyers","year":"1968","unstructured":"Meyers FH, Rose AJ, Smith DE (1968) Incidents involving the Haight-Ashbury population and some uncommonly used drugs. J Psychedelic Drugs 1:139\u2013146","journal-title":"J Psychedelic Drugs"},{"key":"160_CR106","volume-title":"Drugged: the science and culture behind psychotropic drugs","author":"RJ Miller","year":"2014","unstructured":"Miller RJ (2014) Drugged: the science and culture behind psychotropic drugs. University Press, Oxford"},{"key":"160_CR107","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1007\/s11419-014-0247-4","volume":"33","author":"B Moosmann","year":"2015","unstructured":"Moosmann B, Angerer V, Auw\u00e4rter V (2015) Inhomogeneities in herbal mixtures: a serious risk for consumers. Forensic Toxicol 33:54\u201360. https:\/\/doi.org\/10.1007\/s11419-014-0247-4","journal-title":"Forensic Toxicol"},{"key":"160_CR108","doi-asserted-by":"publisher","first-page":"607","DOI":"10.15585\/mmwr.mm6721a4","volume":"67","author":"E Moritz","year":"2018","unstructured":"Moritz E, Austin C, Wahl M, DesLauriers C, Navon L, Walblay K, Hendrickson M, Phillips A, Kerins J, Pennington AF, Lavery AM, El Zahran T, Kauerauf J, Yip L, Thomas J, Layden J (2018) Notes from the field: outbreak of severe illness linked to the vitamin K antagonist brodifacoum and use of synthetic cannabinoids \u2013 Illinois, March\u2013April 2018. MMWR Morb Mortal Wkly Rep 67:607\u2013608. https:\/\/doi.org\/10.15585\/mmwr.mm6721a4","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"160_CR109","unstructured":"Morris H (2012) Criminal chlorination. An interview with a clandestine chemist. Vice. http:\/\/www.vice.com\/read\/criminal-chlorination-0000350-v19n9 . Accessed 11 Jun 2018"},{"key":"160_CR110","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1002\/dta.1620","volume":"6","author":"H Morris","year":"2014","unstructured":"Morris H, Wallach J (2014) From PCP to MXE: a comprehensive review of the non-medical use of dissociative drugs. Drug Test Anal 6:614\u2013632","journal-title":"Drug Test Anal"},{"key":"160_CR111","volume-title":"American disease: origins of narcotic control","author":"DF Musto","year":"1973","unstructured":"Musto DF (1973) American disease: origins of narcotic control. Yale University Press, New York"},{"key":"160_CR112","unstructured":"National Crime Agency (2018) Organised crime group mixed potentially lethal drug fentanyl and posted it around the world. http:\/\/www.nationalcrimeagency.gov.uk\/index.php\/news-media\/nca-news\/1367-organised-crime-group-mixed-potentially-lethal-drug-fentanyl-and-posted-it-around-the-world . Accessed 11 Jun 2018"},{"key":"160_CR113","volume-title":"Synthetic marijuana being banned by U.S","author":"New York Times","year":"1968","unstructured":"New York Times (1968) Synthetic marijuana being banned by U.S. New York Times, New York"},{"key":"160_CR114","doi-asserted-by":"publisher","first-page":"897","DOI":"10.15585\/mmwr.mm6634a2","volume":"66","author":"JK O\u2019Donnell","year":"2017","unstructured":"O\u2019Donnell JK, Gladden RM, Seth P (2017) Trends in deaths involving heroin and synthetic opioids excluding methadone, and law enforcement drug product reports, by census region \u2013 United States, 2006\u20132015. MMWR Morb Mortal Wkly Rep 66:897\u2013903. https:\/\/doi.org\/10.15585\/mmwr.mm6634a2","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"160_CR115","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1097\/01.paf.0000188097.78132.e5","volume":"27","author":"I Ojanper\u00e4","year":"2006","unstructured":"Ojanper\u00e4 I, Gergov M, Rasanen I, Lunetta P, Toivonen S, Tiainen E, Vuori E (2006) Blood levels of 3-methylfentanyl in 3 fatal poisoning cases. Am J Forensic Med Pathol 27:328\u2013331. https:\/\/doi.org\/10.1097\/01.paf.0000188097.78132.e5","journal-title":"Am J Forensic Med Pathol"},{"key":"160_CR116","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/s00414-008-0230-x","volume":"122","author":"I Ojanper\u00e4","year":"2008","unstructured":"Ojanper\u00e4 I, Gergov M, Liiv M, Riikoja A, Vuori E (2008) An epidemic of fatal 3-methylfentanyl poisoning in Estonia. Int J Legal Med 122:395\u2013400. https:\/\/doi.org\/10.1007\/s00414-008-0230-x","journal-title":"Int J Legal Med"},{"key":"160_CR117","volume-title":"Open source intelligence in a networked world","author":"A Olcott","year":"2012","unstructured":"Olcott A (2012) Open source intelligence in a networked world. Continuum, London"},{"key":"160_CR118","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1111\/dar.12356","volume":"35","author":"DR Owen","year":"2016","unstructured":"Owen DR, Wood DM, Archer JR, Dargan PI (2016) Phenibut (4-amino-3-phenyl-butyric acid): availability, prevalence of use, desired effects and acute toxicity. Drug Alcohol Rev 35:591\u2013596. https:\/\/doi.org\/10.1111\/dar.12356","journal-title":"Drug Alcohol Rev"},{"key":"160_CR119","doi-asserted-by":"publisher","first-page":"384","DOI":"10.3109\/15563650.2016.1165952","volume":"54","author":"C Pap","year":"2016","unstructured":"Pap C (2016) ADB-Fubinaca in the real world: a case series of 15 poisonings. 36th international congress of the European Association of Poisons Centres and Clinical Toxicologists (EAPCCT) 24\u201327 May 2016, Madrid, Spain. Clin Toxicol (Phila) 54:384. https:\/\/doi.org\/10.3109\/15563650.2016.1165952","journal-title":"Clin Toxicol (Phila)"},{"key":"160_CR120","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1080\/15563650.2018.1457818","volume":"56","author":"C Pap","year":"2018","unstructured":"Pap C (2018) 5F-MDMB-PINACA on the streets: case series of 17 poisonings. 38th international congress of the European Association of Poisons Centres and Clinical Toxicologists (EAPCCT) 22\u201325 May 2018, Bucharest, Romania. Clin Toxicol (Phila) 56:51. https:\/\/doi.org\/10.1080\/15563650.2018.1457818","journal-title":"Clin Toxicol (Phila)"},{"key":"160_CR121","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1080\/02791072.2015.1128580","volume":"48","author":"T Passie","year":"2016","unstructured":"Passie T, Benzenhofer U (2016) The history of MDMA as an underground drug in the United States, 1960\u20131979. J Psychoactive Drugs 48:67\u201375","journal-title":"J Psychoactive Drugs"},{"key":"160_CR122","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1002\/dta.2292","volume":"10","author":"T Passie","year":"2018","unstructured":"Passie T, Benzenhofer U (2018) MDA, MDMA, and other \u201cmescaline-like\u201d substances in the US military\u2019s search for a truth drug (1940s to 1960s). Drug Test Anal 10:72\u201380","journal-title":"Drug Test Anal"},{"key":"160_CR123","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1124\/pr.112.007138","volume":"65","author":"GW Pasternak","year":"2013","unstructured":"Pasternak GW, Pan YX (2013) Mu opioids and their receptors: evolution of a concept. Pharmacol Rev 65:1257\u20131317. https:\/\/doi.org\/10.1124\/pr.112.007138","journal-title":"Pharmacol Rev"},{"key":"160_CR124","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1093\/bja\/aen094","volume":"100","author":"KT Pattinson","year":"2008","unstructured":"Pattinson KT (2008) Opioids and the control of respiration. Br J Anaesth 100:747\u2013758. https:\/\/doi.org\/10.1093\/bja\/aen094","journal-title":"Br J Anaesth"},{"key":"160_CR125","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.forsciint.2016.12.031","volume":"271","author":"MR Peace","year":"2017","unstructured":"Peace MR, Krakowiak RI, Wolf CE, Poklis A, Poklis JL (2017) Identification of MDMB-FUBINACA in commercially available e-liquid formulations sold for use in electronic cigarettes. Forensic Sci Int 271:92\u201397. https:\/\/doi.org\/10.1016\/j.forsciint.2016.12.031","journal-title":"Forensic Sci Int"},{"key":"160_CR126","doi-asserted-by":"publisher","first-page":"E625","DOI":"10.1208\/aapsj070364","volume":"7","author":"RG Pertwee","year":"2005","unstructured":"Pertwee RG (2005) The therapeutic potential of drugs that target cannabinoid receptors or modulate the tissue levels or actions of endocannabinoids. AAPS J 7:E625\u2013E654. https:\/\/doi.org\/10.1208\/aapsj070364","journal-title":"AAPS J"},{"key":"160_CR127","volume-title":"Handbook of experimental pharmacology","author":"RG Pertwee","year":"2015","unstructured":"Pertwee RG (2015) Endocannabinoids. In: Handbook of experimental pharmacology. Springer, Cham"},{"key":"160_CR128","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1093\/acprof:oso\/9780199662685.003.0006","volume-title":"Handbook of Cannabis","author":"RG Pertwee","year":"2014","unstructured":"Pertwee RG, Cascio MG (2014) Known pharmacological actions of delta-9-tetrahydrocannabinol and four other chemical constituents of cannabis that activate cannabinoid receptors. In: Pertwee R (ed) Handbook of Cannabis. Oxford University Press, Oxford, pp 115\u2013136"},{"key":"160_CR129","first-page":"7","volume":"63","author":"AJ Poortman-van der Meer","year":"1996","unstructured":"Poortman-van der Meer AJ, Huizer H (1996) First encounter with p-fluorofentanyl in the Netherlands. Toxichem Krimtech 63:7\u201314","journal-title":"Toxichem Krimtech"},{"key":"160_CR130","unstructured":"Proposal for a Council Decision on the information exchange, risk-assessment and the control on new narcotic drugs and new synthetic drugs 2003\/0215 (CNS) (2003) http:\/\/eur-lex.europa.eu\/legal-content\/EN\/TXT\/?uri=CELEX:52003PC0560 . Accessed 11 Jun 2018"},{"key":"160_CR131","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.drugpo.2016.10.006","volume":"40","author":"P Quintana","year":"2017","unstructured":"Quintana P, Ventura M, Grifell M, Palma A, Galindo L, Forn\u00eds I, Gil C, Carb\u00f3n X, Caudevilla F, Farr\u00e9 M, Torrens M (2017) The hidden web and the fentanyl problem: detection of ocfentanil as an adulterant in heroin. Int J Drug Policy 40:78\u201383. https:\/\/doi.org\/10.1016\/j.drugpo.2016.10.006","journal-title":"Int J Drug Policy"},{"key":"160_CR132","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.drugpo.2016.10.003","volume":"40","author":"R Ralphs","year":"2017","unstructured":"Ralphs R, Williams L, Askew R, Norton A (2017) Adding spice to the porridge: the development of a synthetic cannabinoid market in an English prison. Int J Drug Policy 40:57\u201369. https:\/\/doi.org\/10.1016\/j.drugpo.2016.10.003","journal-title":"Int J Drug Policy"},{"key":"160_CR133","doi-asserted-by":"publisher","first-page":"974","DOI":"10.2105\/AJPH.2007.110593","volume":"98","author":"N Rasmussen","year":"2008","unstructured":"Rasmussen N (2008a) America's first amphetamine epidemic 1929-1971: a quantitative and qualitative retrospective with implications for the present. Am J Public Health 98:974\u2013985. https:\/\/doi.org\/10.2105\/AJPH.2007.110593","journal-title":"Am J Public Health"},{"key":"160_CR134","volume-title":"On speed. From Benzedrine to Adderall","author":"N Rasmussen","year":"2008","unstructured":"Rasmussen N (2008b) On speed. From Benzedrine to Adderall. NYU Press, New York"},{"key":"160_CR135","first-page":"23","volume-title":"Prescribed: writing, filling, using, and abusing the prescription in modern America","author":"N Rasmussen","year":"2012","unstructured":"Rasmussen N (2012) Goofball panic. Barbiturates, \u201cdangerous\u201d and addictive drugs, and the regulation of medicine in postwar America. In: Greene J, Watkins E (eds) Prescribed: writing, filling, using, and abusing the prescription in modern America. Johns Hopkins University Press, Baltimore, pp 23\u201345"},{"key":"160_CR136","volume-title":"The cannabinoids receptors","year":"2009","unstructured":"Reggio PH (ed) (2009) The cannabinoids receptors. Humana Press, New York"},{"key":"160_CR137","unstructured":"Regulation (EC) No 1920\/2006 of the European Parliament and of the Council of 12 December 2006 on the European Monitoring Centre for Drugs and Drug Addiction (recast) (2006) Off J Eur Union L376:1\u201313. https:\/\/eur-lex.europa.eu\/legal-content\/EN\/TXT\/?uri=celex:32006R1920"},{"key":"160_CR138","unstructured":"Regulation (EU) 2017\/2101 of the European Parliament and of the Council of 15 November 2017 amending Regulation (EC) No 1920\/2006 as regards information exchange on, and an early warning system and risk assessment procedure for, new psychoactive substances (2017) Off J Eur Union L305:1\u20137. https:\/\/eur-lex.europa.eu\/legal-content\/en\/ALL\/?uri=CELEX:32017R2101"},{"key":"160_CR139","volume-title":"Generation ecstasy: into the world of techno and rave culture","author":"S Reynolds","year":"1999","unstructured":"Reynolds S (1999) Generation ecstasy: into the world of techno and rave culture. Routledge, New York"},{"key":"160_CR140","volume-title":"Secret knowledge. Psychedelics and religious experiences","author":"WA Richards","year":"2016","unstructured":"Richards WA (2016) Secret knowledge. Psychedelics and religious experiences. Columbia University Press, New York"},{"key":"160_CR141","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1093\/bja\/aeg279","volume":"91","author":"R Romberg","year":"2003","unstructured":"Romberg R, Sarton E, Teppema L, Matthes HW, Kieffer BL, Dahan A (2003) Comparison of morphine-6-glucuronide and morphine on respiratory depressant and antinociceptive responses in wild type and mu-opioid receptor deficient mice. Br J Anaesth 91:862\u2013870. https:\/\/doi.org\/10.1093\/bja\/aeg279","journal-title":"Br J Anaesth"},{"key":"160_CR142","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1038\/npp.2017.60","volume":"42","author":"BA Samuels","year":"2017","unstructured":"Samuels BA, Nautiyal KM, Kruegel AC, Levinstein MR, Magalong VM, Gassaway MM, Grinnell SG, Han J, Ansonoff MA, Pintar JE, Javitch JA, Sames D, Hen R (2017) The behavioral effects of the antidepressant tianeptine require the mu-opioid receptor. Neuropsychopharmacology 42:2052\u20132063. https:\/\/doi.org\/10.1038\/npp.2017.60","journal-title":"Neuropsychopharmacology"},{"key":"160_CR143","unstructured":"San Francisco Department of Public Health (SFDPH) (2015) Severe opioid overdoses in San Francisco caused by fentanyl-containing \u201cXanax\u201d pill. http:\/\/www.sfcdcp.org\/document.html?id=1005 . Accessed 11 Jun 2018"},{"key":"160_CR144","volume-title":"Enhancing human capacities","year":"2011","unstructured":"Savulescu J, Meulen RT, Kahane G (eds) (2011) Enhancing human capacities. Wiley, Chichester"},{"key":"160_CR145","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/s11419-013-0186-5","volume":"31","author":"M Sch\u00e4ffer","year":"2013","unstructured":"Sch\u00e4ffer M, Gr\u00f6ger T, P\u00fctz M, Zimmermann R (2013) Assessment of the presence of damiana in herbal blends of forensic interest based on comprehensive two-dimensional gas chromatography. Forensic Toxicol 31:251\u2013262. https:\/\/doi.org\/10.1007\/s11419-013-0186-5","journal-title":"Forensic Toxicol"},{"key":"160_CR146","first-page":"112","volume":"83","author":"J Sch\u00e4per","year":"2016","unstructured":"Sch\u00e4per J (2016) Wirkstoffgehalte und inhomogene Verteilung des Wirkstoffs MDMB-CHMICA in Kr\u00e4utermischungen. Toxichem Krimtech 83:112\u2013114","journal-title":"Toxichem Krimtech"},{"key":"160_CR147","volume-title":"Tastes of paradise. A social history of spices, stimulants, and intoxicants","author":"W Schivelbusch","year":"1993","unstructured":"Schivelbusch W (1993) Tastes of paradise. A social history of spices, stimulants, and intoxicants. Vintage Books, New York"},{"key":"160_CR148","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1080\/15563650701877374","volume":"46","author":"H Schumann","year":"2008","unstructured":"Schumann H, Erickson T, Thompson TM, Zautcke JL, Denton JS (2008) Fentanyl epidemic in Chicago, Illinois and surrounding Cook County. Clin Toxicol (Phila) 46:501\u2013506. https:\/\/doi.org\/10.1080\/15563650701877374","journal-title":"Clin Toxicol (Phila)"},{"key":"160_CR149","doi-asserted-by":"publisher","first-page":"6301","DOI":"10.1007\/s00216-015-8612-7","volume":"407","author":"V Shevyrin","year":"2015","unstructured":"Shevyrin V, Melkozerov V, Nevero A, Eltsov O, Shafran Y, Morzherin Y, Lebedev AT (2015) Identification and analytical characteristics of synthetic cannabinoids with an indazole-3-carboxamide structure bearing a N-1-methoxycarbonylalkyl group. Anal Bioanal Chem 407:6301\u20136315. https:\/\/doi.org\/10.1007\/s00216-015-8612-7","journal-title":"Anal Bioanal Chem"},{"key":"160_CR150","doi-asserted-by":"publisher","first-page":"405","DOI":"10.3109\/15563657508990076","volume":"8","author":"AT Shulgin","year":"1975","unstructured":"Shulgin AT (1975) Drugs of abuse in the future. Clin Tox (Phila) 8:405\u2013456","journal-title":"Clin Tox (Phila)"},{"key":"160_CR151","unstructured":"Single Convention on Narcotic Drugs 1961 as amended by the 1972 Protocol (1961) https:\/\/www.unodc.org\/unodc\/en\/treaties\/single-convention.html . Accessed 11 Jun 2018"},{"key":"160_CR152","doi-asserted-by":"publisher","DOI":"10.7551\/mitpress\/8572.001.0001","volume-title":"Prime movers of globalization. The history and impact of diesel engines and gas turbines","author":"V Smil","year":"2010","unstructured":"Smil V (2010) Prime movers of globalization. The history and impact of diesel engines and gas turbines. MIT Press, Cambridge"},{"key":"160_CR153","doi-asserted-by":"publisher","DOI":"10.1002\/0470015535","volume-title":"Drug discovery: a history","author":"W Sneader","year":"2005","unstructured":"Sneader W (2005) Drug discovery: a history. Wiley, Chichester. https:\/\/doi.org\/10.1002\/0470015535"},{"key":"160_CR154","unstructured":"S\u00f6dert\u00f6rns Tingsr\u00e4tt (2018) Tv\u00e5 br\u00f6der d\u00f6ms f\u00f6r \u00e5tta fall av grovt v\u00e5llande till annans d\u00f6d f\u00f6r f\u00f6rs\u00e4ljning av fentanylanaloger p\u00e5 internet. http:\/\/www.sodertornstingsratt.domstol.se\/Om-tingsratten\/Nyheter-och-pressmeddelanden\/Tva-broder-doms-for-atta-fall-av-grovt-vallande-till-annans-dod-for-forsaljning-av-fentanylanaloger-pa-internet\/ . Accessed 11 Jun 2018"},{"key":"160_CR155","doi-asserted-by":"publisher","first-page":"382","DOI":"10.15585\/mmwr.mm6614a2","volume":"66","author":"NJ Somerville","year":"2017","unstructured":"Somerville NJ, O\u2019Donnell J, Gladden RM, Zibbell JE, Green TC, Younkin M, Ruiz S, Babakhanlou-Chase H, Chan M, Callis BP, Kuramoto-Crawford J, Nields HM, Walley AY (2017) Characteristics of fentanyl overdose \u2013 Massachusetts, 2014\u20132016. MMWR Morb Mortal Wkly Rep 66:382\u2013386. https:\/\/doi.org\/10.15585\/mmwr.mm6614a2","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"160_CR156","first-page":"28","volume":"4","author":"VI Sorokin","year":"1994","unstructured":"Sorokin VI (1994) Clandestine synthesis of 3-methylfentanyl. J Clan Lab Invest Chem Assoc 4:28\u201329","journal-title":"J Clan Lab Invest Chem Assoc"},{"key":"160_CR157","first-page":"221","volume":"27","author":"VI Sorokin","year":"1994","unstructured":"Sorokin VI, Semkin EP, Savilov AP (1994) Expert examination of 3-methylfentanyl. Microgram 27:221\u2013226","journal-title":"Microgram"},{"key":"160_CR158","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-84996-139-4","volume-title":"Electronic value exchange. Origins of the VISA electronic payment system","author":"EL Stearns","year":"2011","unstructured":"Stearns EL (2011) Electronic value exchange. Origins of the VISA electronic payment system. Springer, London. https:\/\/doi.org\/10.1007\/978-1-84996-139-4"},{"key":"160_CR159","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-55214-4_11-1","volume-title":"Handbuch psychoaktive substanzen","author":"H Sumnall","year":"2016","unstructured":"Sumnall H (2016) Epidemiology of use of novel psychoactive substances. In: von Heyden M, Jungaberle H, Maji\u0107 T (eds) Handbuch psychoaktive substanzen. Springer, Berlin. https:\/\/doi.org\/10.1007\/978-3-642-55214-4_11-1"},{"key":"160_CR160","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1002\/dta.310","volume":"3","author":"HR Sumnall","year":"2011","unstructured":"Sumnall HR, Evans-Brown M, McVeigh J (2011) Social, policy, and public health perspectives on new psychoactive substances. Drug Test Anal 3:515\u2013523. https:\/\/doi.org\/10.1002\/dta.310","journal-title":"Drug Test Anal"},{"key":"160_CR161","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1111\/acem.13034","volume":"24","author":"ME Sutter","year":"2017","unstructured":"Sutter ME, Gerona RR, Davis MT, Roche BM, Colby DK, Chenoweth JA, Adams AJ, Owen KP, Ford JB, Black HB, Albertson TE (2017) Fatal fentanyl: one pill can kill. Acad Emerg Med 24:106\u2013113. https:\/\/doi.org\/10.1111\/acem.13034","journal-title":"Acad Emerg Med"},{"key":"160_CR162","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/7854_2016_60","volume-title":"Neuropharmacology of New Psychoactive Substances (NPS): the science behind the headlines","author":"S Tai","year":"2017","unstructured":"Tai S, Fantegrossi WE (2017) Pharmacological and toxicological effects of synthetic cannabinoids and their metabolites. In: Baumann MH, Glennon RA, Wiley JL (eds) Neuropharmacology of New Psychoactive Substances (NPS): the science behind the headlines. Springer, Cham, pp 249\u2013262. https:\/\/doi.org\/10.1007\/7854_2016_60"},{"key":"160_CR163","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/15563650.2015.1110590","volume":"54","author":"RJ Tait","year":"2016","unstructured":"Tait RJ, Caldicott D, Mountain D, Hill SL, Lenton S (2016) A systematic review of adverse events arising from the use of synthetic cannabinoids and their associated treatment. Clin Toxicol (Phila) 54:1\u201313. https:\/\/doi.org\/10.3109\/15563650.2015.1110590","journal-title":"Clin Toxicol (Phila)"},{"key":"160_CR164","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.15585\/mmwr.mm6647a3","volume":"66","author":"L Tapp","year":"2017","unstructured":"Tapp L, Ramsey JG, Wen A, Gerona R (2017) Synthetic cannabinoid and mitragynine exposure of law enforcement agents during the raid of an illegal laboratory \u2013 Nevada, 2014. MMWR Morb Mortal Wkly Rep 66:1291\u20131294. https:\/\/doi.org\/10.15585\/mmwr.mm6647a3","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"4","key":"160_CR165","doi-asserted-by":"publisher","first-page":"107","DOI":"10.15585\/mm6604a4","volume":"66","author":"AJ Tomassoni","year":"2017","unstructured":"Tomassoni AJ, Hawk KF, Jubanyik K, Nogee DP, Durant T, Lynch KL, Patel R, Dinh D, Ulrich A, D\u2019Onofrio G (2017) Multiple fentanyl overdoses \u2013 new haven, Connecticut, June 23, 2016. MMWR Morb Mortal Wkly Rep 66(4):107\u2013111. https:\/\/doi.org\/10.15585\/mm6604a4","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"160_CR166","volume-title":"The age of anxiety: a history of America\u2019s turbulent affair with tranquilizers","author":"A Tone","year":"2008","unstructured":"Tone A (2008) The age of anxiety: a history of America\u2019s turbulent affair with tranquilizers. Basic Books, New York"},{"key":"160_CR167","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1056\/NEJMp1505328","volume":"373","author":"J Trecki","year":"2015","unstructured":"Trecki J, Gerona RR, Schwartz MD (2015) Synthetic cannabinoid-related illnesses and deaths. N Engl J Med 373:103\u2013107. https:\/\/doi.org\/10.1056\/NEJMp1505328","journal-title":"N Engl J Med"},{"issue":"6","key":"160_CR168","doi-asserted-by":"publisher","first-page":"e41","DOI":"10.1002\/phar.2117","volume":"38","author":"U Uddayasankar","year":"2018","unstructured":"Uddayasankar U, Lee C, Oleschuk C, Eschun G, Ariano RE (2018) The pharmacokinetics and pharmacodynamics of carfentanil after recreational exposure: a case report. Pharmacotherapy 38(6):e41\u2013e45. https:\/\/doi.org\/10.1002\/phar.2117","journal-title":"Pharmacotherapy"},{"key":"160_CR169","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1007\/s11419-017-0367-8","volume":"35","author":"I Ujv\u00e1ry","year":"2017","unstructured":"Ujv\u00e1ry I, Jorge R, Christie R, Le Ruez T, Danielsson HV, Kronstrand R, Elliott S, Gallegos A, Sedefov R, Evans-Brown M (2017) Acryloylfentanyl, a recently emerged new psychoactive substance: a comprehensive review. Forensic Toxicol 35:232\u2013243. https:\/\/doi.org\/10.1007\/s11419-017-0367-8","journal-title":"Forensic Toxicol"},{"key":"160_CR170","unstructured":"United States Centers for Disease Control and Prevention (US CDC) (2015) Increases in fentanyl drug confiscations and fentanyl-related overdose fatalities. CDCHAN-00384. https:\/\/emergency.cdc.gov\/han\/han00384.asp . Accessed 11 Jun 2018"},{"key":"160_CR171","unstructured":"United States Centers for Disease Control and Prevention (US CDC) (2018) Outbreak of life-threatening coagulopathy associated with synthetic cannabinoids use. CDCHAN-00410. https:\/\/emergency.cdc.gov\/han\/han00410.asp . Accessed 11 Jun 2018"},{"key":"160_CR172","unstructured":"United States Department of Justice (US DOJ) (2018) Schedules of controlled substances: temporary placement of fentanyl-related substances in schedule I. Fed Regist 83:5188\u20135192. https:\/\/www.federalregister.gov\/d\/2018-02319 . Accessed 11 Jun 2018"},{"key":"160_CR173","unstructured":"United States InterAgency Board for Equipment Standardization and Interoperability (US IABESI) (2017) Recommendations on selection and use of personal protective equipment and decontamination products for first responders against exposure hazards to synthetic opioids, including fentanyl and fentanyl analogues. https:\/\/www.interagencyboard.org\/sites\/default\/files\/publications\/IAB First Responder PPE and Decontamination Recommendations for Fentanyl.pdf . Accessed 11 Jun 2018"},{"key":"160_CR174","unstructured":"United States White House National Security Council (US WHNSC) (2017) Fentanyl safety recommendations for first responders. https:\/\/www.whitehouse.gov\/sites\/whitehouse.gov\/files\/images\/Final%20STANDARD%20size%20of%20Fentanyl%20Safety%20Recommendations%20for%20First%20Respond\u2026.pdf . Accessed 11 Jun 2018"},{"key":"160_CR175","unstructured":"User Voice (2016) Spice: the bird killer \u2013 what prisoners think about the use of spice and other legal highs in prison. http:\/\/www.uservoice.org\/wp-content\/uploads\/2016\/05\/User-Voice-Spice-The-Bird-Killer-Report-Low-Res.pdf . Accessed 11 Jun 2018"},{"key":"160_CR176","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1046\/j.1360-0443.1999.9479612.x","volume":"94","author":"JM White","year":"1999","unstructured":"White JM, Irvine RJ (1999) Mechanisms of fatal opioid overdose. Addiction 94:961\u2013972. https:\/\/doi.org\/10.1046\/j.1360-0443.1999.9479612.x","journal-title":"Addiction"},{"key":"160_CR177","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/7854_2016_17","volume-title":"Neuropharmacology of New Psychoactive Substances (NPS): the science behind the headlines","author":"JL Wiley","year":"2017","unstructured":"Wiley JL, Marusich JA, Thomas BF (2017) Combination chemistry: structure\u2013activity relationships of novel psychoactive cannabinoids. In: Baumann MH, Glennon RA, Wiley JL (eds) Neuropharmacology of New Psychoactive Substances (NPS): the science behind the headlines. Springer, Cham, pp 231\u2013248. https:\/\/doi.org\/10.1007\/7854_2016_17"},{"key":"160_CR178","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1002\/hup.2292","volume":"28","author":"AR Winstock","year":"2013","unstructured":"Winstock AR, Barratt MJ (2013) The 12-month prevalence and nature of adverse experiences resulting in emergency medical presentations associated with the use of synthetic cannabinoid products. Hum Psychopharmacol 28:390\u2013393. https:\/\/doi.org\/10.1002\/hup.2292","journal-title":"Hum Psychopharmacol"},{"key":"160_CR179","volume-title":"International health regulations (2005) and chemical events","author":"World Health Organization (WHO)","year":"2015","unstructured":"World Health Organization (WHO) (2015) International health regulations (2005) and chemical events. World Health Organization, Geneva"},{"key":"160_CR180","unstructured":"World Health Organization (WHO) (2018) International health regulations. http:\/\/www.who.int\/topics\/international_health_regulations\/en\/ . Accessed 11 Jun 2018"},{"key":"160_CR181","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1093\/jat\/bkx061","volume":"41","author":"O Yeter","year":"2017","unstructured":"Yeter O (2017) Identification of the synthetic cannabinoid 1-(4-cyanobutyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide (CUMYL-4CN-BINACA) in plant material and quantification in post-mortem blood samples. J Anal Toxicol 41:720\u2013728. https:\/\/doi.org\/10.1093\/jat\/bkx061","journal-title":"J Anal Toxicol"},{"key":"160_CR182","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s13181-016-0558-4","volume":"12","author":"M Zaurova","year":"2016","unstructured":"Zaurova M, Hoffman RS, Vlahov D, Manini AF (2016) Clinical effects of synthetic cannabinoid receptor agonists compared with marijuana in emergency department patients with acute drug overdose. J Med Toxicol 12:335\u2013340. https:\/\/doi.org\/10.1007\/s13181-016-0558-4","journal-title":"J Med Toxicol"}],"container-title":["Handbook of Experimental Pharmacology","New Psychoactive Substances"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/164_2018_160","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T02:13:24Z","timestamp":1720577604000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/164_2018_160"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"ISBN":["9783030105600","9783030105617"],"references-count":182,"URL":"https:\/\/doi.org\/10.1007\/164_2018_160","relation":{},"ISSN":["0171-2004","1865-0325"],"issn-type":[{"value":"0171-2004","type":"print"},{"value":"1865-0325","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018]]},"assertion":[{"value":"8 September 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}